Research & Publications
Melinda L. Irwin, PhD, MPH is Associate Dean of Research and Professor of Epidemiology at the Yale School of Public Health, Associate Director (Population Sciences) in the Yale Cancer Center, Co-Program Leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, and Deputy Director (Public Health) in the Yale Center for Clinical Investigation. Nationally, Dr. Irwin co-leads the SWOG Cancer Research Network Cancer Survivorship Committee.Dr. Irwin is a prominent leader in the field of lifestyle factors and cancer prevention and control. Her research over the past 20 years has focused on randomized trials of exercise and weight loss on biological markers, treatment side effects and quality of life in cancer patients and survivors. She has received funding from the NIH, ACS, American Institute for Cancer Research, Komen for the Cure, and Livestrong Foundation.She is currently examining the impact of nutrition and exercise on improving chemotherapy completion rate, endocrine therapy adherence, biomarkers, body composition and quality of life in an NCI-funded R01 trial in women beginning chemotherapy for breast cancer. Dr. Irwin is committed to training the next generation of scientists, and is currently leading an NCI R25-funded international effort focused on training early career investigators in energy balance and cancer research entitled the Transdisciplinary Research on Energetics and Cancer (TREC) Training Program. At Yale, Dr. Irwin has advised, mentored and trained over 100 trainees on public health related studies. Dr. Irwin also serves on various national advisory committees to develop consensus statements on physical activity, diet, weight and cancer prevention and control.
Education & Training
- MPHUniversity of Washington (2001)
- PhDUniversity of South Carolina (1999)
- MSUniversity of North Carolina at Chapel Hill (1994)
- BSCollege of William and Mary (1992)